
Boceprevir With Peginterferon Alfa-2a-Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection
Keywords: مهارکننده پروتئاز; Protease Inhibitor; Antiviral Therapy; Clinical Trial; Liver Disease; AE; adverse event; BOC; boceprevir; BOC/PEG2a/R; boceprevir plus peginterferon alfa-2a-ribavirin; CI; confidence interval; HCV; hepatitis C virus; OR; odds ratio; PEG2a; peginterferon